-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Agios Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- Agios Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$103M, a 1.9% decline year-over-year.
- Agios Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$407M, a 5.88% decline year-over-year.
- Agios Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$391M, a 0.63% decline from 2022.
- Agios Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$389M, a 2.81% decline from 2021.
- Agios Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$378M, a 12.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)